Precision Medicine

Technological advances combined with an improved understanding of the genetic basis of cancer has allowed individualized profiling that is revolutionizing personalized medicine and cancer treatment.

With minimal volumes of blood, CIRCULOGENE’s patented technology utilizes next-generation sequencing (NGS) and reverse-transcriptase (RT-PCR) to monitor thousands of known tumor mutations in the following scientifically established, cancer-associated genes:

Click here to read descriptions of individual genes.

ABL1
AKT1
ALK
APC
ATM
BRAF
BRCA1 (somatic/germline)
BRCA2 (somatic/germline)
CDH1
CDKN2A
CSF1R
CTNNB1
EGFR
ERBB2
ERBB4
EZH2
FBXW7

FGFR1
FGFR2
FGFR3
FLT3
GNA11
GNAQ
GNAS
HNF1A
HRAS
IDH1
IDH2
JAK2
JAK3
KDR
KIT
KRAS
MET
MLH1
MPL

NOTCH1
NPM1
NRAS
NTRK1 (Coming soon)
NTRK2 (Coming soon)
NTRK3 (Coming soon)
PDGFRA
PIK3CA
PTEN
PTPN11
RB1
RET
SMAD4
SMARCB1
SMO
SRC
STK11
TP53
VHL